We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Enzo Biochem Secures FDA Emergency Use Authorization for Proprietary Coronavirus Detection Test System

By LabMedica International staff writers
Posted on 14 Jul 2020
Enzo Biochem (New York, NY, USA) has received Emergency Use Authorization (EUA) from the FDA for its proprietary product for the detection of Coronavirus SARS-CoV-2 enabling other laboratories to use the company’s products with three diverse platforms without requiring further validation. More...


The AMPIPROBE SARS-CoV-2 Test System is a complete workflow solution based on the real-time reverse transcription polymerase chain reaction (qRT-PCR) technology and designed for the qualitative detection of nucleic acids from SARS-CoV-2 virus. It features improved scale, high sensitivity, particularly relevant positive controls comprising in vitro transcribed viral RNA, and RNaseP as an internal control to confirm the quality of the specimen collection and the nucleic acid extraction process. The AMPIPROBE SARS-Cov-2 Test System includes AMPICOLLECT Saline, Normal for sample collection of upper respiratory specimens (such as nasal, mid-turbinate, nasopharyngeal, oropharyngeal swab specimens and nasopharyngeal wash/aspirate or nasal aspirate specimens), the AMPIXTRACT SARS-CoV-2 Extraction Kit, AMPIPROBE SARS-CoV-2 Assay Kit and AMPIPROBE SARS-CoV-2 Controls kit, and the high-throughput GENFLEX platform.

Pursuant to receiving the Emergency Use Authorization, Enzo’s diagnostics division is offering the AMPIPROBE SARS-Cov-2 Test System for use with three platforms. The first platform is Enzo’s proprietary automated GENFLEXTM platform, which is a high-throughput, sample-to-result open molecular diagnostics system that delivers high capacity, efficiency, and flexibility at a lower price point than competing systems. The second platform is for the use of Enzo’s proprietary test for detection and analysis in conjunction with nucleic acid extraction on the QIAsymphony SP platform. Lastly, the FDA has authorized the use of Enzo’s proprietary test on a manual workflow.

“This is an important milestone for Enzo as the FDA’s EUA on three disparate systems demonstrates the flexibility and adaptability of our highly reliable and sensitive PCR-based molecular test for SARS-Cov-2,” said Elazar Rabbani, Ph.D., Enzo CEO. “The EUA builds upon our comprehensive COVID-19 program and the diagnostic testing efforts we first announced in April, which have already garnered significant interest from government entities, nursing homes, and universities as they plan testing programs for their constituents.”

Related Links:
Enzo Biochem


Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Portable Electronic Pipette
Mini 96
New
Gold Member
Hematology Analyzer
Medonic M32B
New
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.